China, Nov. 4 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effect of ropivacaine combined with dexmedetomidine femoral artery block on thigh tourniquet-induced hypertension'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135869

Registration Time: 2026/11/03

Type: Interventional study

Primary Sponsor: The First People's Hospital of Nantong

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=347154

Published by HT Digital Content Services with permission from Health Daily Digest....